trastuzumab deruxtecan,medi-57527,Pembrolizumab
daiichi sankyo,astrazeneca,Merck,MedImmune
['lung', 'destiny,lung02']
dr. discusses the destiny-lung02 data at #esmo22 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him